CVS, NCOA extend senior health program
WOONSOCKET, R.I. CVS Caremark and the National Council on Aging have extended by three years their joint “Prescription for Better Health” program that has been underway since 2007.
The announcement was made Thursday at the Aging in America Conference in Washington, D.C. The program provides improved access to health education and senior benefits through the nationwide networks of more than 6,300 stores and NCOA’s Senior Center members and other affiliated community-based organizations.
Components of the program include medication management, educational resources, access to information on benefits programs through the NCOA BenefitsCheckUp tool and health screenings and flu vaccinations.
Going forward, a new component of the program will be joint CVS and NCOA research initiatives to yield new insights on seniors and medication trends.
ScriptPro robotic dispensing adopted in two Haggen locations
BELLINGHAM, Washington Haggen Food & Pharmacy has added ScriptPro’s robotic dispensing devices to two of its stores, one in Ferndale and the other in Barkley Village, according to published reports.
The system automatically selects a prescription vial, counts tablets or capsules into the vial and labels it with patient, drug and dosing information.
“This system offers many advantages for our customers,” said Andrew Charter, vice president of pharmacy at Haggen Inc. “It is better than partially automated systems in providing accurately counted doses. Most importantly, it frees up our pharmacists to spend more time answering the questions of customers rather than counting pills or making labels.”
Eli Lilly, Sanofi-Aventis partner to market Cialis
BRDIGEWATER, N.J. Sanofi-Aventis has agreed to help Eli Lilly market its impotency drug Cialis, according to CNN. Financial terms were not disclosed.
Lilly gained full rights to the medicine at the beginning of 2007, when it bought the drug from ICOS for $2.3 billion.
Cialis had worldwide sales of $1.1 billion in 2007, compared with its main competitor Pfizer’s Viagra, which saw sales of $1.76 billion.